Relation between carotid intima media thickness and oxidative stress markers in type 1 diabetic children and adolescents

Journal of Diabetes and Metabolic Disorders

Volumn 12, Issue 1, 2013, Pages

  El Samahy, Mona H ^a   Matter, Randa M ^a   Youssef, Omneya I ^a   Shams El Din El Telbany, Manal A ^a   Kamal, Nermeen A ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TRIACYLGLYCEROL;

ADOLESCENT; AGE; ANTIOXIDANT ACTIVITY; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BODY MASS; CHILD; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OXIDATIVE STRESS; SYSTOLIC BLOOD PRESSURE;

EID: 84908091959     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-12-50     Document Type: Article

References (56)

1. Rabago Rodriguez R, Gómez-Díaz RA, Tanus Haj J, Avelar Garnica FJ, Ramirez Soriano E, Nishimura Meguro E, Aguilar-Salinas CA, Wacher NH. Carotid intima-media thickness in pediatric type 1 diabetic patients. Diabetes Care 2007, 30(suppl 10):2599-2602.
2. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987, 3:463-524. 10.1002/dmr.5610030206, 3552530.
3. Daneman D. Type 1 diabetes. Lancet 2006, 367:847-858. 10.1016/S0140-6736(06)68341-4, 16530579.
4. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 1974, 23:105-111.
5. Järvisalo MJ, Jartti L, Näntö-Salonen K, Irjala K, Rönnemaa T, Hartiala JJ, Celermajer DS, Raitakari OT. Increased aortic intima-media thickness. A marker of preclinical atherosclerosis in high-risk children. Circulation 2001, 104:2943-2947. 10.1161/hc4901.100522, 11739310.
6. Glagov S, Weisenberg E, Zarins CK, Stankonavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987, 316:1371-1375. 10.1056/NEJM198705283162204, 3574413.
7. Parikh A, Danemann D. Is carotid ultrasound a useful tool in assessing cardiovascular disease in individuals with diabetes?. Diabetes Technol Ther 2004, 6:65-69. 10.1089/152091504322783440, 15000773.
8. De Groot E, Hovingh K, Wiegman A, Duriez P, Smit AJ, Fruchart JC, Kastelein JJP. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation 2004, 109:33-38.
9. Stabouli S, Kotsis V, Papamichael C, Constantinopoulos A, Zakopoulos N. Adolescent obesity is associated with high ambulatory blood pressure and increased carotid intimal-medial thickness. J Pediatr 2005, 147:651-656. 10.1016/j.jpeds.2005.06.008, 16291358.
10. Jourdan C, Wuhl E, Litwin M, Fahr K, Trelewicz J, Jobs K, Schenk JP, Grenda R, Mehls O, Troger J, Schaefer F. Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 2005, 23:1707-1715. 10.1097/01.hjh.0000178834.26353.d5, 16093916.
11. Litwin M, Wuhl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F. Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 2005, 16:1494-1500. 10.1681/ASN.2004110932, 15772249.
12. Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38. 10.1002/jbt.10058, 12616644.
13. Guillermo Z, Fortuño A, Díez J. Oxidative stress and atherosclerosis in early chronic kidney disease. Nephrol Dial Transplant 2006, 21:2686-2690. 10.1093/ndt/gfl398, 16861737.
14. Wolff SP. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the etiology of diabetes mellitus and complications. Br Med Bull 1993, 49:642-652.
15. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820. 10.1038/414813a, 11742414.
16. Wieruszwysocka B, Wysocki H, Byks H, Zozulinska D, Wykretowicz A, Kazierczak M. Metabolic control quality and free radical activity in diabetic patients. Diabetes Res Clin Pract 1995, 27:193-197. 10.1016/0168-8227(95)01043-D, 7555601.
17. Heistad Donald D. Oxidative Stress and VascularDisease. Arterioscler Thromb Vasc Biol 2005, 26:689-695.
18. Liu Shang X, Hou Fan F, Guo Zhi J, Nagai R, Zhang Wei R, Liu Zhi Q, Zhou Zhan M, Zhou M, Di X, Wang Guo B, Zhang X. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 2006, 26:1156-1162. 10.1161/01.ATV.0000214960.85469.68, 16497990.
19. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010, 107:1058-1070. 10.1161/CIRCRESAHA.110.223545, 2996922, 21030723.
20. Joshi MS, Ponthier JL, Lancaster JR. Cellular antioxidant and pro-oxidant actions of nitric oxide. Free Radic Biol Med 1999, 27:1357-1366. 10.1016/S0891-5849(99)00179-3, 10641730.
21. Vallence P. Vascular nitric oxide in health and disease. Nitric Oxide Biology andPathobiology 2000, 921-930. San Diego, CA: Academic, Ignarro L.
22. Yamagishi S, Matsui T. Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy-Friend or foe?. Pharmacol Res 2011, 64(3):187-194. 10.1016/j.phrs.2011.05.009, 21635951.
23. Celik S, Akkaya H. Total antioxidant capacity, catalase and superoxide dismutase on rats before and after diabetes. J Anim Vet Adv 2009, 8:1503-1508.
24. Opara EC, Abdel-Rahman E, Soliman S, Kamel WA, Souka S, Lowe JE, Abdel-Aleem S. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 1999, 48:1414-1417. 10.1016/S0026-0495(99)90152-X, 10582550.
25. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ. International Society for Pediatric and Adolescent Diabetes (ISBAD) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2007, 8:408-418. 10.1111/j.1399-5448.2007.00352.x, 18036070.
26. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, Steffes MW, Striker GE, Viberti GC. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995, 346:1080-1084. 10.1016/S0140-6736(95)91747-0, 7564792.
27. Warnick GR, Wood PD. National Cholesterol Education Program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995, 41:1427-1433.
28. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001, 54:356-361. 10.1136/jcp.54.5.356, 1731414, 11328833.
29. Miles AM, Wink DA, Cook JC, Grisham MB. Determination of nitric oxide using fluorescence spectroscopy. Methods Enzymol 1996, 268:105-120.
30. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986, 74:1399-1406. 10.1161/01.CIR.74.6.1399, 3536154.
31. Abou-Seif MA, Youssef AA. Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 2004, 346:161-170. 10.1016/j.cccn.2004.03.030, 15256317.
32. Astaneie F, Afshari M, Mojtahedi A, Mostafalou S, Zamani MJ, Larijani B, Abdollahi M. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 2005, 36(4):376-381. 10.1016/j.arcmed.2005.03.007, 15950078.
33. Di Nardo W, Pitocco D, Di Leo MA, Picciotti PM, Di Stasio E, Collina C, Santini S, Scarano E, Ghirlanda G. Modifications in nasal function and nitric oxide serum level in type 1 diabetes. J Otolaryngol Head Neck Surg 2008, 37:611-615.
34. Pitocco D, Zaccardi F, Di Stasio E, Romitelli F, Martini F, Scaglione GL, Speranza D, Santini S, Zuppi C, Ghirlanda G. Role of asymmetric-dimethyl-L-arginine (ADMA) and nitrite/nitrate (NOx) in the pathogenesis of oxidative stress in female subjects with uncomplicated type 1 diabetes mellitus. Diabetes Res Clin Pract 2009, 86:173-176. 10.1016/j.diabres.2009.09.019, 19836094.
35. Horoz OO, Yuksel B, Bayazit AK, Attila G, Sertdemir Y, Mungan NO, Topaloglu AK, Ozer G. Ambulatory blood pressure monitoring and serum nitric oxide concentration in type 1 diabetic children. Endocr J 2009, 56:477-485. 10.1507/endocrj.K08E-338, 19225212.
36. Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F, Mezzetti A. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 2000, 49:1258-1263. 10.2337/diabetes.49.7.1258, 10909986.
37. Prabhakar SS. Role of nitric oxide in diabetic nephropathy. Semin Nephrol 2004, 24:333-344. 10.1016/j.semnephrol.2004.04.005, 15252773.
38. Iwanicka Z, Lewandowicz-Uszyska A, Gab E, Kotschy B. Relationship between nitrogen oxide and the degree of metabolic control of diabetes mellitus type 1 in children and adolescents. Wiad Lek 2006, 59:27-31.
39. Telci A, Cakatay U, Salman S, Satman I, Sivas A. Oxidative protein damage in early stage Type 1 diabetic patients. Diabetes Res Clin Pract 2000, 50:213-223.
40. Marra G, Cotroneo P, Pitocco D, Manto A, Di Leo MA, Ruotolo V, Caputo S, Giardina B, Ghirlanda G, Santini SA. Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference. Diabetes Care 2002, 25:370-375. 10.2337/diacare.25.2.370, 11815512.
41. Varvarovska J, Racek J, Stozicky F, Soucek J, Trefil L, Pomahacova R. Parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives. J Diab Complicat 2003, 17:7-10.
42. Suys B, de Beeck LO, Rooman R, Kransfeld S, Heuten H, Goovaerts I, Vrints C, de Wolf D, Matthys D, Manuel-y-Keenoy B. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase?. Pediatr Res 2007, 62:456-461. 10.1203/PDR.0b013e318142581a, 17667843.
43. El-desoky MA, Amin AE, El-refai MO, Farid RJ, Labib AA. Evaluation of Some Biochemical Changes in Diabetic Patients. The Egyptian Journal of Hospital Medicine 2013, 50:150-155.
44. Margeirsdottir HD, Stensaeth KH, Larsen JR, Brunborg C, Dahl-Jorgensen K. Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-basedstudy. Diabetes Care 2010, 33:2043-2048. 10.2337/dc10-0505, 2928360, 20530748.
45. Jarvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimaki T, Ronnemaa T, Viikari J, Raitakari OT. Endothelial dysfunction and increased arterial intima media thickness in children with type 1 diabetes. Circulation 2004, 109:1750-1755. 10.1161/01.CIR.0000124725.46165.2C, 15023875.
46. Abdelghaffar S, El Amir M, El Hadidi A, El Mougi F. Carotid intima-media thickness: an index for subclinical atherosclerosis in type 1 diabetes. J Trop Pediatr 2006, 52:39-45. 10.1093/tropej/fmi071, 16000343.
47. Gul K, Ustun I, Aydin Y, Berker D, Erol K, Unal M, Barazi AO, Delibai T, Guler S. Carotid intima-media thickness and its relations with the complications in patients with type 1 diabetes mellitus. Anadolu Kardiyol Derg 2010, 10:52-58.
48. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S, . Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group Intensive diabetes therapy and carotid intima-mediathickness in type 1 diabetes mellitus. N Engl J Med 2003, 348:2294-2303. 2701300, 12788993, Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Research Group.
49. Jarvisalo MJ, Putto-Laurila A, Jartti L, Lehtimaki T, Solakivi T, Ronnemaa T, Raitakari OT. Carotid Artery Intima-Media Thickness in Children with Type 1 Diabetes. Diabetes 2002, 51:493-498. 10.2337/diabetes.51.2.493, 11812760.
50. Dalla Pozza R, Bechtold S, Bonfig W, Putzker S, Kozlik-Feldmann R, Netz H, Schwarz HP. Age of onset of type 1 diabetes in children and carotid intima medial thickness. J Clin Endocrinol Metab 2007, 92:2053-2057. 10.1210/jc.2006-2868, 17374703.
51. Dursun B, Dursun E, Suleymanlar G, Ozben B, Capraz I, Apaydin A, Ozben T. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotidartery intima-media thickness with oxidative stress. J Diabetes Complications 2009, 23:257-264. 10.1016/j.jdiacomp.2007.12.007, 18413174.
52. Zineh I, Beitelshees AL, Haller MJ. NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes. Diabetes Care 2007, 30:689-693. 10.2337/dc06-1697, 17327342.
53. Muniyappa R, Quon MJ. Insulin action and insulin resistance in vascular endothelium. Curr Opin Clin Nutr Metab Care 2007, 10(4):523-530. 10.1097/MCO.0b013e32819f8ecd, 17563474.
54. Faienza MF, Acquafredda A, Tesse R, Luce V, Ventura A, Maggialetti N, Monteduro M, Giordano P, Cavallo L. Risk factors for subclinical atherosclerosis in diabetic and obese children. Int J Med Sci 2013, 10(3):338-343. 10.7150/ijms.5181, 3575630, 23423872.
55. Nojiri S, Daida H, Mokuno H, Iwama Y, Mae K, Ushio F, Ueki T. Association of serum antioxidant capacity with coronary artery disease in middle-aged men. Jpn Heart J 2001, 42:677-690. 10.1536/jhj.42.677, 11933918.
56. Demirbag R, Yilmaz R, Kocyigit A. Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat Res 2005, 570:197-203. 10.1016/j.mrfmmm.2004.11.003, 15708578.